다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
한국식품위생안전성학회지 = Journal of food hygiene and safety, v.36 no.5, 2021년, pp.363 - 375
Chelliah, Ramachandran (Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University) , Daliri, Eric Banan-Mwine (Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University) , Elahi, Fazle (Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University) , Yeon, Su-Jung (Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University) , Tyagi, Akanksha (Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University) , Park, Chae Rin (Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University) , Kim, Eun Ji (Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University) , Jo, kyoung Hee (Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University) , Oh, Deog-Hwan (Department of Food Science and Biotechnology, College of Agricul)
AI-Helper
Trends in the developing era to discover and design peptide-based treatments throughout an epidemic infection scenario such as COVID-19 could progress into a more efficient and low-cost therapeutic environment. However, the weakening of proteolysis is one downside of natural peptide drugs. But, pept...
Alqahtani, J.S., Oyelade, T., Aldhahir, A.M., Alghamdi, S.M., Almehmadi, M., Alqahtani, A.S., Quaderi, S., Mandal, S., Hurst, J.R., Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One, 15, e0233147 (2020).
Johns Hopkins Univ., (2021, September 23). Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Retrieved from https://coronavirus.jhu.edu/map.html
Graham, B.S., Sullivan, N.J., Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic. Nat. immunol., 19, 20-28 (2018).
Bieganska-Banas, J.M., Makara-Studzinska, M., Coping strategies among nurses during the COVID-19 outbreak. Problemy Pielegniarstwa, 28, 1-11 (2020).
Goldsmith, C.S., Miller, S.E., Martines, R.B., Bullock, H.A., Zaki, S.R., Electron microscopy of SARS-CoV-2: a challenging task. The Lancet, 395, e99 (2020).
Sanchis-Gomar, F., Lavie, C.J., Perez-Quilis, C., Henry, B.M., Lippi, G., Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019. Mayo Clin. Proc., 95, 1222-1230 (2020).
Sharma, R.K., Stevens, B.R., Obukhov, A.G., Grant, M.B., Oudit, G.Y., Li, Q., Richards, E.M., Pepine, C.J., Raizada, M.K., ACE2 (Angiotensin-Converting Enzyme 2) in cardiopulmonary diseases: ramifications for the control of SARS-CoV-2. Hypertension, 76, 651-661 (2020).
Outlaw, V.K., Bovier, F.T., Mears, M.C., Cajimat, M.N., Zhu, Y., Lin, M.J., Addetia, A., Lieberman, N.A., Peddu, V., Xie, X., Shi, P.Y., Greninger, A.L., Gellman, S.H., Bente, D.A., Moscona, A., Porotto, M., Inhibition of coronavirus entry in vitro and ex vivo by a lipid-conjugated peptide derived from the sars-cov-2 spike glycoprotein hrc domain. mBio, 11, (2020).
VanPatten, S., He, M., Altiti, A., Cheng, K.F., Ghanem, M.H., Al-Abed, Y., Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics. Future Med. Chem., 12, 1647-1656 (2020).
Beniac, D.R., Booth, T.F., 2010. Structural molecular insights into SARS coronavirus cellular attachment, entry and morphogenesis, In Molecular Biology of the SARS-Coronavirus. Springer, Berlin, Heidelberg, pp. 31-43
Zhao, G.P., SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era. Philos. Trans. R. Soc. Lond B Biol. Sci., 362, 1063-1081 (2007).
Anand, K.B., Karade, S., Sen, S., Gupta, R.M., SARS-CoV-2: camazotz's curse. Med. J. Armed Forces India, 76, 136-141 (2020).
Gandhi, L., Rodriguez-Abreu, D., Gadgeel, S., Esteban, E., Felip, E., De Angelis, F., Domine, M., Clingan, P., Hochmair, M.J., Powell, S.F., Cheng, S.Y.S, Bischoff, H.G., Peled, N., Grossi, F., Jennens, R.R., Reck, M., Hui, R., Garon, E.B., Boyer, M., Rubio-Viqueira, B., Novello, S., Kurata, T., Gray, J.E., Vida, J., Wei, Z., Yang, J., Raftopoulos, H., Pietanza, M.C., Garassino, M.C., Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N. Engl. J. Med., 378, 2078-2092 (2018).
Zhang, H., Penninger, J.M., Li, Y., Zhong, N., Slutsky, A.S., Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med., 46, 586-590 (2020).
Lohi, H., Kujala, M., Makela, S., Lehtonen, E., Kestila, M., Saarialho-Kere, U., Markovich, D., Kere, J., Functional characterization of three novel tissue-specific anion exchangers SLC26A7,-A8, and-A9. J. Biol. Chem., 277, 14246-14254 (2002).
Wei, C., Wan, L., Yan, Q., Wang, X., Zhang, J., Yang, X., Zhang, Y., Fan, C., Li, D., Deng, Y., Sun, J., Gong, J., Yang, X., Wang, Y., Wang, X., Li, J., yang, H., Li, H., Zhang, Z., Wang, R., Du, P., Zong, Y., Yin, F., Zhang, W., Wang, N., Peng, Y., Lin, H., Feng, J., Qin, C., Chen, W., Gao, Q., Zhang, R., Cao, Y., Zhong, H., HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat. Metab., 2, 1391-1400 (2020).
Ye, M., Wysocki, J., Gonzalez-Pacheco, F.R., Salem, M., Evora, K., Garcia-Halpin, L., Poglitsch, M., Schuster, M., Batlle, D., Murine Recombinant Angiotensin-Converting Enzyme 2: Effect on Angiotensin II-Dependent Hypertension and Distinctive Angiotensin-Converting Enzyme 2 Inhibitor Characteristics on Rodent and Human Angiotensin-Converting Enzyme 2. Hypertension, 60, 730-740 (2012).
Drozdzal, S., Rosik, J., Lechowicz, K., Machaj, F., Kotfis, K., Ghavami, S., & Los, M. J., FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Drug Resist. Updat., 100719 (2020).
Pillaiyar, T., Wendt, L.L., Manickam, M., Easwaran, M., The recent outbreaks of human coronaviruses: A medicinal chemistry perspective. Med. Res. Rev., 41, 72-135 (2021).
Banting, F.G., Best, C.H., Collip, J.B., Campbell, W.R., Fletcher, A.A., Pancreatic Extracts in The Treatment of Diabetes Mellitus. Diabetes, 5, 69-71 (1956).
Elkinton, J.R., Hunt, A.D., Godfrey, L., McCrory, W.; Rogerson, A.; Stokes, J. Effects of pituitary adrenocorticotropic hormone (ACTH) therapy. JAMA, 141, 1273-1279 (1949)
Lau, J.L., Dunn, M.K., Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & medicinal chemistry, 26, 2700-2707 (2018).
Hollenstein, K., de Graaf, C., Bortolato, A., Wang, M.W., Marshall, F.H., Stevens, R.C., Insights into the structure of class B GPCRs. Trends in pharmacological sciences, 35, 12-22 (2014).
Agoulnik, A.I., Agoulnik, I.U., Hu, X., Marugan, J., Synthetic non?peptide low molecular weight agonists of the relaxin receptor 1. Br. J. Pharmacol., 174, 977-989 (2017).
Mishra, R.K., Shum, A.K., Platanias, L.C., Miller, R.J., Schiltz, G.E., Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists. Sci. Rep., 6, 1-9 (2016).
Sacks, L.V., Shamsuddin, H.H., Yasinskaya, Y.I., Bouri, K., Lanthier, M.L., Sherman, R.E., Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012. JAMA, 311, 378-384 (2014).
Hollenberg, N.K., Williams, G.H., Burger, B., Ishikawa, I., Adams, D.F., Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man. J. Clin. Invest., 57, 39-46 (1976).
Mullard, A., Once-yearly device takes on daily and weekly diabetes drugs. Nat. Biotechnol. 32, 1178 (2014).
Camacho, P.M., Petak, S.M., Binkley, N., Clarke, B.L., Harris, S.T., Hurley, D.L., Kleerekoper, M., Lewiecki, E.M., Miller, P.D., Narula, H.S., Pessah-Pollack, R., Tangpricha, V., Wimalawansa, S.J., Watts, N.B., American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2016--Executive Summary. Endocr. Pract., 22, 1111-1118 (2016).
Stupp, R., Hegi, M.E., Gorlia, T., Erridge, S.C., Perry, J., Hong, Y.K., Aldape, K.D., Lhermitte, B., Pietsch, T., Grujicic, D., Steinbach, J.P., Wick, W., Tarnawski, R., Nam, D.H., Hau, P., Weyerbrock, A., Taphoorn, M.J., Shen, C.C., Rao, N., Thurzo, L., Herrlinger, U., Gupra, T., Kortmann, R.D., Adamska, K., McBain, C., Brandes, A.A., Tonn, J.C., Schnell, O., Wiegel, T., Kim, C.Y., Nabors, L.B., Reardon, D.A., van den Bent, M.J., Hicking, C., Markivskyy, A., Picard, M., Wller, M., Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol., 15, 1100-1108 (2014).
Chang, Y.S., Graves, B., Guerlavais, V., Tovar, C., Packman, K., To, K.H., Olson, K.A., Kesavan, K., Gangurde, P., Mukherjee, A., Baker, T., Darlak, K., Elkin, C., Filipovic, Z., Qureshi, F.Z., Cai, H., Berry, P., Feyfant, E., Shi, X.E., Horstick, J., Annis, D.A., Manning, A.M., Fotouhi, N., Nash, H., Vassilev, L.T., Sawyer, T.K., Stapled α- helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy. Proc. Natl. Acad. Sci. U S A., 110, E3445-E3454 (2013).
Meerovitch, K., Torkildsen, G., Lonsdale, J., Goldfarb, H., Lama, T., Cumberlidge, G., Ousler III, G.W., Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye. Clin. Ophthalmol., 7, 1275-1285 (2013).
Birk, A.V., Liu, S., Soong, Y., Mills, W., Singh, P., Warren, J.D., Seshan, S.V., Pardee, J.D., Szeto, H.H., The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J. Am. Soc. Nephrol., 24, 1250-1261 (2013).
Li, Q., Zhao, Z., Zhou, D., Chen, Y., Hong, W., Cao, L., Yang, J., Zhang, Y., Shi, W., Cao, Z., Wu, Y., Yan, H., Li, W., Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. Peptides, 32, 1518-1525 (2011).
Jaiswal, G., Kumar, V., In-silico design of a potential inhibitor of SARS-CoV-2 S protein. PLoS One, 15, e0240004 (2020).
Xia, S., Zhu, Y., Liu, M., Lan, Q., Xu, W., Wu, Y., Ying, T., Liu, S., Shi, Z., Jiang, S., Lu, L., Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell. Mol. Immunol., 17, 765-767 (2020).
Xu, J., Jia, W., Wang, P., Zhang, S., Shi, X., Wang, X., Zhang, L., Antibodies and vaccines against Middle East respiratory syndrome coronavirus. Emerg. Microbes infect., 8, 841-856 (2019).
Xia, S., Yan, L., Xu, W., Agrawal, A.S., Algaissi, A., Tseng, C.T.K., Wang, Q., Du, L., Tan, W., Wilson, I.A., Jiang, S., Yang, B., Lu, L., A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci. Adv., 5, eaav4580 (2019).
Izzo, C., Grillo, F., Murador, E., Improved method for determination of high-density-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000. Clin. Chem., 27, 371-374 (1981).
Channappanavar, R., Lu, L., Xia, S., Du, L., Meyerholz, D.K., Perlman, S., Jiang, S., Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection. J. Infect. Dis., 212, 1894-1903 (2015).
Schutz, D., Ruiz-Blanco, Y.B., Munch, J., Kirchhoff, F., Sanchez-Garcia, E., Muller, J.A., Peptide and peptide-based inhibitors of SARS-CoV-2 entry. Adv. Drug Deliv. Rev., 167, 47-65 (2020).
Baik, M., The mechanism of small molecule viral fusion inhibitors. PhD thesis, University of Alabama at Birmingham, Birmingham, Alabama (2015).
Dawood, A.A., Mutated COVID-19 may foretell a great risk for mankind in the future. New Microbes and New Infections, 35, 100673 (2020).
Rathod, S.B., Prajapati, P.B., Punjabi, L.B., Prajapati, K.N., Chauhan, N., Mansuri, M.F., Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2. In silico pharmacol., 8, 1-9 (2020).
Yang, D., Application of Nanotechnology in the COVID-19 Pandemic. Int J. Nanomedicine, 16, 623-649 (2021).
Memariani, H., Memariani, M., Therapeutic and prophylactic potential of anti-microbial peptides against coronaviruses. Ir. J. Med. Sci., 189, 1153-1154 (2020).
Henson, P.M., Bratton, D.L., 2009. Phagocyte-Pathogen Interactions: Macrophages and the Host Responses to Infection, American Society for Microbiology, Washington, D.C, DC, USA, pp. 341-365
Sousa, F.H., Casanova, V., Stevens, C., Barlow, P.G., 2016. Antiviral host defence peptides. Host Defense Peptides and Their Potential as Therapeutic Agents, Springer, Cham, pp. 57-94.
Albar, A.H., Almehdar, H.A., Uversky, V.N., Redwan, E.M., Structural heterogeneity and multifunctionality of lactoferrin. Curr. Protein Pept. Sci., 15, 778-797 (2014).
Smith, S.A., Kotwa, G.J., Immune response to poxvirus infections in various animals. Crit. Rev. Microbiol., 28, 149-185 (2002).
Hodinka, R. L., Respiratory RNA viruses. Microbiol. Spectr., 4, doi: 10.1128/microbiolspec.DMIH2-0028-2016 (2016).
Wang, H., Chen, Q., Zhou, S., Carbon-based hybrid nanogels: a synergistic nanoplatform for combined biosensing, bioimaging, and responsive drug delivery. Chem. Soc. Rev., 47, 4198-4232 (2018).
El-Subbagh, N.H., Rabie, R., Mahfouz, A.A., Aboelsuod, K.M., Elshabrawy, M.Y., Abdelaleem, H.M., Elhammady, B.E., Abosaleh, W., Salama, L.A., Badreldeen, S., Yasser, M., Elgaml, A., Characteristic Features of Coronavirus Disease-2019 (COVID-19) Pandemic: Attention to the Management and Control in Egypt. Journal of Disaster Research, 16, 70-83 (2021).
Dayrit, Fabian M., Mary T., Newport, M.D., 2020. The Potential of Coconut Oil as an Effective and Safe Antiviral Agent Against the Novel Coronavirus (nCoV-2019), pp. 1-4.
Sun, B., Jia, L., Liang, B., Chen, Q., Liu, D., Phylogeography, transmission, and viral proteins of Nipah virus. Virol. Sin., 33, 385-393 (2018).
Zhang, Q., Wang, Y., Qi, C., Shen, L., Li, J., Clinical trial analysis of 2019?nCoV therapy registered in China. J. Med. Virol., 92, 540-545 (2020).
Abbara, A., Jayasena, C.N., Christopoulos, G., Narayanaswamy, S., Izzi-Engbeaya, C., Nijher, G.M.K., Comninos, A.N., Peters, D., Buckley, A., Ratnasabapathy, R., Prague, J.K., Salim, R., Lavery, S.A., Bloom, S.R., Szigeti, M., Ashby, D.A., Trew, G.H., Dhillo, W.S., Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy. J. Clin. Endocrinol. Metab., 100, 3322-3331 (2015).
Ling, L.L., Schneider, T., Peoples, A.J., Spoering, A.L., Engels, I., Conlon, B.P., Mueller, A., Schaberle, T.F., Hughes, D.E., Epstein, S., Jones, M., Lazardes, L., Steadman, V.A., Cohen, D.R., Felix, C.R., Fetterman, K.A., Millett, W.P., Nitti, A.G., Zullo, A.M., Chen, C., Lewis, K., A new antibiotic kills pathogens without detectable resistance. Nature, 517, 455-459 (2015).
Motley, J.L., Stamps, B.W., Mitchell, C.A., Thompson, A.T., Cross, J., You, J., Powell, D.R., Stevenson, B.S., Cichewicz, R.H., Opportunistic sampling of roadkill as an entry point to accessing natural products assembled by bacteria associated with non-anthropoidal mammalian microbiomes. J. Nat. Prod., 80, 598-608 (2017).
Lavergne, V., Harliwong, I., Jones, A., Miller, D., Taft, R.J., Alewood, P.F., Optimized deep-targeted proteotranscriptomic profiling reveals unexplored Conus toxin diversity and novel cysteine frameworks. PNAS, 112, E3782-E3791 (2015).
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., Saha, P.K., Del Solar, M., Zhu, B., York, B., Sarkar, P., Rendon, D.A., Gaber, M.W., LeMaire, S.A., Coselli, J.S., Milewicz, D.M., Sutton, V.R., Butte, N.F., Moore, D.D., Chopra, A.R., Asprosin, a fasting-induced glucogenic protein hormone. Cell, 165, 566-579 (2016).
Walther, A., Riehemann, K., Gerke, V., A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. cell, 5, 831-840 (2000).
Figshare, (2021, September 23). Rapid multiplication of COVID Virus. Retrieved from https://figshare.com/s/1fcd33018c5cfd7e11ee
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.